Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis-Reference-Cited by-同舟云学术

Randomized controlled trial to evaluate the efficacy and safety of fexuprazan compared with esomeprazole in erosive esophagitis

Published:2022-11-28 Issue:44 Volume:28 Page:6294-6309
ISSN:1007-9327
Container-title:World Journal of Gastroenterology
language:
Short-container-title:World J Gastroenterol

Author:

Lee Kang Nyeong,Lee Oh Young,Chun Hoon Jai,Kim Jin Il,Kim Sung Kook,Lee Sang Woo,Park Kyung Sik,Lee Kook Lae,Choi Suck Chei,Jang Jae-Young,Kim Gwang Ha,Sung In-kyung,Park Moo In,Kwon Joong Goo,Kim Nayoung,Kim Jae Jun,Lee Soo Teik,Kim Hyun Soo,Kim Ki Bae,Lee Yong Chan,Choi Myung-Gyu,Lee Joon Seong,Jung Hwoon-Yong,Lee Kwang Jae,Kim Jie-Hyun,Chung Hyunsoo

Publisher

Baishideng Publishing Group Inc.

Subject

Gastroenterology,General Medicine

Reference44 articles.

1. Guidelines for the Diagnosis and Management of Gastroesophageal Reflux Disease

2. The global, regional, and national burden of gastro-oesophageal reflux disease in 195 countries and territories, 1990–2017: a systematic analysis for the Global Burden of Disease Study 2017

3. Global prevalence of, and risk factors for, gastro-oesophageal reflux symptoms: a meta-analysis

4. Erosive Esophagitis and Nonerosive Reflux Disease (NERD)

5. Differences in Clinical Characteristics between Patients with Non-Erosive Reflux Disease and Erosive Esophagitis in Korea

Cited by 24 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. AGA Clinical Practice Update on Integrating Potassium-Competitive Acid Blockers Into Clinical Practice: Expert Review;Gastroenterology;2024-09

2. Experimental drugs for erosive esophagitis: what is in the clinical development pipeline?;Expert Opinion on Investigational Drugs;2024-08-30

3. Scalable Synthesis of the Key Fexuprazan Intermediate and Investigation of a Reaction Mechanism;ACS Omega;2024-08-23

4. Efficacy and safety of fexuprazan in patients with symptoms and signs of laryngopharyngeal reflux disease: a randomized clinical trial;European Archives of Oto-Rhino-Laryngology;2024-08-08

5. Treatment Response With Potassium-competitive Acid Blockers Based on Clinical Phenotypes of Gastroesophageal Reflux Disease: A Systematic Literature Review and Meta-analysis;Journal of Neurogastroenterology and Motility;2024-07-30